NasdaqGS - Delayed Quote USD

Surgery Partners, Inc. (SGRY)

23.83 +0.41 (+1.75%)
At close: April 19 at 4:00 PM EDT
23.83 0.00 (0.00%)
After hours: April 19 at 4:03 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 10101111
Avg. Estimate 0.070.190.991.27
Low Estimate 0.020.130.781.16
High Estimate 0.120.231.121.49
Year Ago EPS 0.080.2810.99

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 991010
Avg. Estimate 697.42M728.8M3.01B3.27B
Low Estimate 688M708M3B3.24B
High Estimate 726.82M737.3M3.02B3.32B
Year Ago Sales 666.2M667.6M2.74B3.01B
Sales Growth (year/est) 4.70%9.20%9.60%8.80%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 00.080.160.38
EPS Actual 0.080.280.190.44
Difference 0.080.20.030.06
Surprise % --250.00%18.80%15.80%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.070.190.991.27
7 Days Ago 0.080.1911.28
30 Days Ago 0.080.1911.28
60 Days Ago 0.120.211.061.37
90 Days Ago 0.110.21.051.33

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --1--1
Down Last 7 Days --------
Down Last 30 Days 1111

Growth Estimates

CURRENCY IN USD SGRYIndustrySectorS&P 500
Current Qtr. -12.50%----1.60%
Next Qtr. -32.10%----10.50%
Current Year -1.00%----5.20%
Next Year 28.30%----13.30%
Next 5 Years (per annum) 45.50%----11.22%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

35.00
42.36 Average
23.83 Current
50.00 High

Fair Value

Near Fair Value
% Return
23.83 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Reiterates Cantor Fitzgerald: Overweight to Overweight 4/10/2024
Initiated Barclays: Equal-Weight 3/6/2024
Reiterates Cantor Fitzgerald: Overweight to Overweight 3/5/2024
Reiterates RBC Capital: Outperform to Outperform 2/29/2024
Maintains Citigroup: Buy to Buy 2/27/2024
Maintains Cantor Fitzgerald: Overweight to Overweight 2/27/2024

Related Tickers